ATC Group: A06AD15 Macrogol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A06AD15 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Laxatives
3
Laxatives
4
Osmotically acting laxatives
5
A06AD15
Macrogol

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
10 g

Active ingredients in A06AD15

Active Ingredient
Description

High molecular weight (4000) macrogols are long linear polymers which retain water molecules by means of hydrogen bonds. When administered by the oral route, they lead to an increase in volume of intestinal fluids.

Medicines in this ATC group

Drug
Countries

Spain Turkey

Lithuania

Austria Estonia France Hong Kong Lithuania ...

Ireland

Australia

Australia

Australia Austria Finland France Ireland ...

Ecuador

Austria Estonia Finland Lithuania Poland ...

Australia Tunisia

Ireland United Kingdom

Finland Poland

Finland

Canada

Ireland United Kingdom

Related product monographs

Title
Type
Country
Medication Package Insert (MPI)
ZA
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
IE